Kailera Therapeutics, Inc. (KLRA)

NASDAQ: KLRA · Real-Time Price · USD

19.90

+0.77 (4.03%)

At close: Jun 18, 2026, 4:00 PM EDT

19.51

-0.39 (-1.96%)

After-hours: Jun 18, 2026, 7:12 PM EDT

Kailera Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025
Cash & Equivalents	111.83	160.27
Short-Term Investments	407.35	385.79
Cash & Short-Term Investments	519.17	546.06
Other Current Assets	11.14	11.48
Total Current Assets	530.32	557.54
Net Property, Plant & Equipment	12.02	12.42
Long-Term Investments	62.75	106.67
Other Long-Term Assets	19.67	15.67
Total Assets	624.76	692.29
Accounts Payable	7.1	7.53
Accrued Expenses	46.71	37.84
Current Portion of Leases	1.03	1.04
Total Current Liabilities	54.84	46.41
Long-Term Leases	9.44	9.71
Other Long-Term Liabilities	0.2	0.27
Total Long-Term Liabilities	9.64	9.98
Total Liabilities	64.48	56.39
Additional Paid-in Capital	15.98	11.98
Accumulated Other Comprehensive Income	-0.53	0.23
Retained Earnings	-447.53	-368.67
Total Common Shareholders' Equity	-432.09	-356.46
Minority Interest	992.36	992.36
Shareholders' Equity	560.28	635.91
Total Liabilities & Equity	624.76	692.29
Total Debt	10.47	10.75
Net Cash (Debt)	508.7	535.3
Net Cash Growth	-4.97%	-
Net Cash Per Share	16983.41	3409573.25
Book Value	-432.09	-356.46
Book Value Per Share	-14425.50	-2270430.00
Tangible Book Value	-432.09	-356.46
Tangible Book Value Per Share	-14425.50	-2270430.00

SEC Filings: 10-K · 10-Q